Meza, Luis
City Of Hope National Medical Center · Yale University · City of Hope
2 papers on CoChatORCID 0000-0002-0235-297X
Most cited papers
- Verified
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
Dizman, N., Meza, L., Bergerot, P., Alcantara, M., Dorff, T., Lyou, Y., Frankel, P., Cui, Y., Mira, V., Llamas, M., et al. (2022) · Nature Medicine
Cancer Immunotherapy and BiomarkersRenal cell carcinoma treatment
Cited by 515
- Verified
Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
Ebrahimi, H., Dizman, N., Meza, L., Malhotra, J., Li, X., Dorff, T., Frankel, P., Llamas-Quitiquit, M., Hsu, J., Zengin, Z. B., et al. (2024) · Nature Medicine
Renal cell carcinoma treatmentCancer Immunotherapy and Biomarkers
Cited by 109
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free